| Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 509 | 2022 |
| Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 435 | 2022 |
| Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ... New England Journal of Medicine 387 (17), 1620-1622, 2022 | 122 | 2022 |
| Covid-19 vaccine protection among children and adolescents in Qatar H Chemaitelly, S AlMukdad, HH Ayoub, HN Altarawneh, P Coyle, P Tang, ... New England Journal of Medicine 387 (20), 1865-1876, 2022 | 55 | 2022 |
| Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA. 1 and BA. 2 Omicron infections and severe COVID-19 in Qatar HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... MedRxiv, 2022.03. 22.22272745, 2022 | 46 | 2022 |
| Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant H Altarawneh, H Chemaitelly, P Tang, MR Hasan, S Qassim, HH Ayoub, ... MedRxiv, 2022.01. 05.22268782, 2022 | 44 | 2022 |
| Protection against reinfection with the omicron BA. 2.75 subvariant H Chemaitelly, P Tang, P Coyle, HM Yassine, HA Al-Khatib, MK Smatti, ... New England Journal of Medicine 388 (7), 665-667, 2023 | 42 | 2023 |
| Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design HH Ayoub, M Tomy, H Chemaitelly, HN Altarawneh, P Coyle, P Tang, ... American Journal of Epidemiology 193 (6), 883-897, 2024 | 36 | 2024 |
| Protection of SARS-CoV-2 natural infection against reinfection with the Omicron BA. 4 or BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub medRxiv, 2022 | 32 | 2022 |
| Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: a systematic review AS Aldien, GS Ganesan, F Wahbeh, N Al-Nassr, H Altarawneh, ... Cardiovascular Revascularization Medicine 35, 169-178, 2022 | 32 | 2022 |
| Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... EBioMedicine 95, 2023 | 29 | 2023 |
| DNA barcoding of fish species reveals low rate of package mislabeling in Qatar KC Chen, D Zakaria, H Altarawneh, GN Andrews, GS Ganesan, KM John, ... Genome 62 (2), 69-76, 2019 | 18 | 2019 |
| Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies M Fayyad, NK Majbour, NN Vaikath, D Erskine, H El-Tarawneh, ... Neuroscience Letters 725, 134899, 2020 | 17 | 2020 |
| Drug reaction with eosinophilia and systemic symptoms secondary to naproxen: a case report and literature review S Sasi, H Altarawneh, MA Petkar, AP Nair Case Reports in Acute Medicine 3 (2), 63-72, 2020 | 8 | 2020 |
| Effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection among children and adolescents in Qatar H Chemaitelly, S AlMukdad, HH Ayoub, HN Altarawneh, P Coyle, P Tang, ... medRxiv, 2022.07. 26.22278045, 2022 | 6 | 2022 |
| 1966. Protection afforded by prior infection, vaccination, and hybrid immunity against symptomatic BA. 1 and BA. 2 Omicron infections. HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1591, 2022 | 5 | 2022 |
| Protection against reinfection with SARS-CoV-2 omicron BA.2.75* sublineage H Chemaitelly, P Tang, P Coyle, HM Yassine, HA Al-Khatib, MK Smatti, ... medRxiv, 2022.10. 29.22281606, 2022 | 4 | 2022 |
| Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study IN Petropoulos, F Al-Shibani, G Bitirgen, G Ponirakis, A Khan, H Gad, ... Therapeutic Advances in Neurological Disorders 16, 17562864221118731, 2023 | 3 | 2023 |
| Authorship characteristics of hematology and oncology education chapters: A comprehensive analysis H Altarawneh, M Manasrah, Y Al Shanableh, AS Aldien, MA Manasrah, ... Journal of Cancer Policy 40, 100484, 2024 | | 2024 |
| Authorship characteristics of hematology and oncology education chapters: A comprehensive analysis. MA Manasrah, HN Altarawneh, Y Al Shanableh, AS Aldien, MA Manasrah, ... JCO Oncology Practice 19 (11_suppl), 460-460, 2023 | | 2023 |
